Motus GI Holdings (Motus GI Holdings) Earnings per Share (Diluted) : $-25.89 (TTM As of Dec. 2023)

View and export this data going back to 2018. Start your Free Trial

What is Motus GI Holdings Earnings per Share (Diluted)?

Motus GI Holdings's Earnings per Share (Diluted) for the three months ended in Dec. 2023 was $-1.81. Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was $-25.89.

Motus GI Holdings's EPS (Basic) for the three months ended in Dec. 2023 was $-1.81. Its EPS (Basic) for the trailing twelve months (TTM) ended in Dec. 2023 was $-25.89.

Motus GI Holdings's EPS without NRI for the three months ended in Dec. 2023 was $-1.63. Its EPS without NRI for the trailing twelve months (TTM) ended in Dec. 2023 was $-25.66.

During the past 3 years, the average EPS without NRIGrowth Rate was 55.80% per year. During the past 5 years, the average EPS without NRI Growth Rate was 42.90% per year.

During the past 9 years, Motus GI Holdings's highest 3-Year average EPS without NRI Growth Rate was 55.80% per year. The lowest was -11.40% per year. And the median was 28.60% per year.

Motus GI Holdings Earnings per Share (Diluted) Historical Data

The historical data trend for Motus GI Holdings's Earnings per Share (Diluted) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Motus GI Holdings Earnings per Share (Diluted) Chart

Motus GI Holdings Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Earnings per Share (Diluted)

Get a 7-Day Free Trial

-276.00

-180.00

-161.10

-86.15

-15.89

Motus GI Holdings Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
Earnings per Share (Diluted)	Get a 7-Day Free Trial															-11.85	-13.80	-6.00	-4.28	-1.81

Competitive Comparison of Motus GI Holdings's Earnings per Share (Diluted)

For the Medical Devices subindustry, Motus GI Holdings's PE Ratio, along with its competitors' market caps and PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Motus GI Holdings's PE Ratio Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Motus GI Holdings's PE Ratio distribution charts can be found below:

* The bar in red indicates where Motus GI Holdings's PE Ratio falls into.

Motus GI Holdings Earnings per Share (Diluted) Calculation

Earnings Per Share (EPS) is the amount of earnings per outstanding share of the company's stock. In calculating earnings per share, the dividends of preferred stocks need to subtracted from the total net income first.

Motus GI Holdings's Earnings Per Share (Diluted) for the fiscal year that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (A: Dec. 2023 )	=	(Net Income	-	Preferred Dividends)	/	Shares Outstanding (Diluted Average)
	=	(-12.867	-	0)	/	0.810
	=	-15.89

Motus GI Holdings's Earnings Per Share (Diluted) for the quarter that ended in Dec. 2023 is calculated as

Diluted Earnings Per Share (Q: Dec. 2023 )	=	(Net Income	-	Preferred Dividends	/	Shares Outstanding (Diluted Average)
	=	(-2.805	-	0)	/	1.547
	=	-1.81

Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was $-25.89

Companies also reported diluted shares in their financial reports. Diluted shares include the shares of convertibles or warrants outstanding.

Motus GI Holdings (OTCPK:MOTS) Earnings per Share (Diluted) Explanation

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists EPS without NRI, which better reflects the company's underlying performance.

Be Aware

Compared with Earnings per share, a company's cash flow is better indicator of the company's earnings power.

If a company's earnings per share is less than cash flow per share over long term, investors need to be cautious and find out why.

Motus GI Holdings Earnings per Share (Diluted) Related Terms

Thank you for viewing the detailed overview of Motus GI Holdings's Earnings per Share (Diluted) provided by GuruFocus.com. Please click on the following links to see related term pages.

Motus GI Holdings (Motus GI Holdings) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Motus GI Holdings Inc (OTCPK:MOTS) » Definitions » Earnings per Share (Diluted)

Comparable Companies

Traded in Other Exchanges

N/A

Address

1301 East Broward Boulevard, 3rd Floor, Fort Lauderdale, FL, USA, 33301

Website

https://www.motusgi.com

Motus GI Holdings Inc is a medical technology company dedicated to improving endoscopy outcomes, lowering costs and enhancing patient experiences. The company has developed the Pure-Vu System, a medical device that has been cleared by the U.S. Food and Drug Administration (the "FDA") to help facilitate the cleansing of a poorly prepared gastrointestinal tract during colonoscopy and to help facilitate upper gastrointestinal ("GI") endoscopy procedures. The Pure-Vu System is also CE marked in the European Economic Area (EEA) for use in colonoscopy.

Executives

Orchestra Biomed Holdings, Inc.	10 percent owner	150 UNION SQUARE DRIVE, NEW HOPE PA 18938
Scott Durbin	director	PO BOX 376, ANN ARBOR MI 48106
Elad Amor	officer: Chief Accounting Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Ravit Ram	officer: Chief Financial Officer	MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FORT LAUDERDALE FL 33301
Timothy P. Moran	director, officer: Chief Executive Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Andrew Lawrence Taylor	officer: Chief Financial Officer	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Mark Pomeranz	director, officer: President and COO	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Sonja Nelson	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BOULEVARD, 3RD FLOOR, FT. LAUDERDALE FL 33301
Oracle Partners Lp	other: * See Remarks	200 GREENWICH AVE, 3RD FL, GREENWICH CT 06830
Larry N Feinberg	other: * See Remarks	C/O ORACLE PARTNERS L P, 200 GREENWICH AVENUE, GREENWICH CT 06830
Perceptive Life Sciences Master Fund Ltd	10 percent owner	C/O PERCEPTIVE ADVISORS LLC, 51 ASTOR PLACE, 10TH FLOOR, NEW YORK NY 10003
Darren Sherman	director	C/O MOTUS GI HOLDINGS, INC., 1301 EAST BROWARD BLVD, 3RD FLOOR, FT. LAUDERDALE FL 33301
David P Hochman	director, other: Chairman of the Board	15 WESTON HILL RD., RIVERSIDE CT 06878
Nussbaum Samuel R Md	director	WELLPOINT, INC, 120 MONUMENT CIRCLE, INDIANAPOLIS IN 46204
Shervin J Korangy	director	850 PARK AVENUE, APT. 12B, NEW YORK NY 10075